Medications for Atrial Flutter

26 results
Skyepharma Production SAS
Usage: Betapace/Betapace AF is indicated for treating life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia, and for delaying recurrence of highly symptomatic atrial fibrillation/atrial flutter in patients currently in sinus rhythm. It is not intended for patients with easily reversible paroxysmal atrial fibrillation.

Corvert (ibutilide fumarate)

(ibutilide fumarate)
Pharmacia & Upjohn Company LLC
Usage: CORVERT Injection is indicated for the rapid conversion of recent-onset atrial fibrillation or atrial flutter to sinus rhythm. It is less effective in patients with arrhythmias lasting longer than 90 days, as its effectiveness in such cases has not been established.
Hikma Pharmaceuticals USA Inc.
Usage: Diltiazem Hydrochloride Injection is indicated for temporary control of rapid ventricular rates in atrial fibrillation or flutter and for converting paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm. Continuous monitoring is essential during administration, with emergency equipment on hand.
VGYAAN Pharmaceuticals LLC
Usage: Dofetilide Capsules are indicated for maintaining normal sinus rhythm and delaying recurrence of atrial fibrillation/atrial flutter in symptomatic patients who have been converted to sinus rhythm. They are also used for converting atrial fibrillation/flutter to normal sinus rhythm but are ineffective in paroxysmal cases.
NorthStar RxLLC
Usage: Dofetilide capsules are indicated for maintaining normal sinus rhythm in patients with atrial fibrillation/atrial flutter (AF/AFl) post-conversion and for converting AF/AFl to normal sinus rhythm. It is intended for symptomatic patients and is not effective for paroxysmal AF.
EXELAN PHARMACEUTICALS, INC.
Usage: Dofetilide capsules are indicated for maintaining normal sinus rhythm and delaying the recurrence of atrial fibrillation/atrial flutter in symptomatic patients after conversion. They are also used for converting atrial fibrillation/flutter to normal sinus rhythm, though not effective for paroxysmal atrial fibrillation.

Quinidine (quinidine gluconate)

(Quinidine Gluconate)
Watson Laboratories, Inc.
Usage: Quinidine gluconate is indicated for restoring normal sinus rhythm in symptomatic atrial fibrillation/flutter, reducing relapse frequency in high-risk patients, and suppressing life-threatening ventricular arrhythmias. Caution is advised due to potential proarrhythmic effects, and its use should follow inadequate responses to alternative treatments.
Bayshore Pharmaceuticals LLC
Usage: Sotalol AF is indicated for maintaining normal sinus rhythm in symptomatic patients with atrial fibrillation or atrial flutter. It is reserved for those with severe symptoms and is not recommended for easily reversible cases. It also treats life-threatening ventricular arrhythmias but should not be substituted with other sotalol formulations.
Carilion Materials Management
Usage: Sotalol hydrochloride is indicated for treating life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia. It is also used to maintain normal sinus rhythm in symptomatic atrial fibrillation/flutter patients. Use in less severe arrhythmias is generally not recommended due to potential proarrhythmic effects.
Epic Pharma, LLC
Usage: Sotalol hydrochloride tablets (AF) are indicated for maintaining normal sinus rhythm in symptomatic patients with atrial fibrillation/atrial flutter (AFIB/AFL). They are also used for life-threatening ventricular arrhythmias. Caution is advised due to potential serious side effects; not suitable for easily reversible AFIB/AFL cases.